{"id":526542,"date":"2021-08-11T08:03:38","date_gmt":"2021-08-11T12:03:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/"},"modified":"2021-08-11T08:03:38","modified_gmt":"2021-08-11T12:03:38","slug":"acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/","title":{"rendered":"AcQMap 8, Acutus Medical\u2019s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark"},"content":{"rendered":"

\nEnhanced Software Automatically Identifies Regions of Interest During the Treatment of Complex Atrial Arrhythmias
\n<\/h2>\n
\n

CARLSBAD, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc.<\/a> (Nasdaq: AFIB) (\u201cAcutus\u201d), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced its innovative suite of software upgrades, known collectively as AcQMap 8, has received FDA clearance and been awarded CE Mark. AcQMap 8 introduces advanced new mapping algorithms into Acutus\u2019 foundational technology, the AcQMap 3D imaging and mapping system. These algorithms \u2013 including AcQTrack\u2122 and the SlowZone\u2122 Locator (Composite Maps) \u2013 are designed to quickly highlight regions of interest during the mapping and ablation of complex atrial arrhythmias, the treatment of which has been shown to significantly improve patient outcomes.1<\/sup> The software upgrade also features a series of procedural workflow enhancements and seamless integration of Acutus\u2019 therapeutic ablation technologies, where currently available.<\/p>\n

Unique to Acutus\u2019 full chamber non-contact mapping technology, which is capable of mapping individual beats in real-time, the AcQTrack mapping algorithm is engineered to automatically identify and analyze the presence of three abnormal conduction patterns (focal, partial-rotational and irregular) often associated with atrial fibrillation (AF). In clinical trials such as UNCOVER AF, when three to four of these abnormal conduction patterns were targeted for ablation, patients were nine times more likely to be in sinus rhythm after one year.1<\/sup> AcQTrack functions as an innovative tool that can fit seamlessly into electrophysiologists\u2019 diagnostic workflows and aid in their visual assessment of propagation history maps. Acutus will commence the rollout of AcQMap 8 immediately, update its current installed base of consoles and integrate AcQMap 8 into all new installations.<\/p>\n

\u201cWe\u2019re seeing more and more clearly that the triggers and drivers for some of the most complex atrial arrhythmias lie beyond the reach of traditional pulmonary vein isolation treatment strategies,\u201d said Prof. Tim Betts, M.D., Oxford University Hospitals NHS Foundation Trust. \u201cAcQMap\u2019s multiple algorithms, in combination with its non-contact full chamber mapping capabilities, allows me to better assess potential new areas of interest outside the pulmonary veins in order to achieve a more comprehensive assessment of complex atrial arrhythmias like atrial fibrillation. Algorithms like AcQTrack further extend my confidence to determine and execute treatment strategies specific to each individual patient, which has the potential to significantly improve patient outcomes.\u201d<\/p>\n

In addition to AcQTrack, the SlowZone Locator algorithm represents a pioneering advancement in substrate mapping. It is the first and only mapping algorithm that identifies consistent areas of slow conduction over the entire atrium. With the SlowZone Locator, physicians create one or more maps in the atria, which the algorithm then combines into one composite map for analyzing areas of consistent slow conduction in each patient.<\/p>\n

\u201cI believe these algorithmic functions will have a significant influence on our overall treatment strategies, particularly in complex arrhythmia cases like atrial fibrillation,\u201d said Sarah Hussain, M.D., Penn State Health, Hershey, Penn. \u201cTo be able to clearly see abnormal conduction patterns associated with AF while also having the opportunity to combine several full-chamber maps could provide us with brand new insights about the mechanisms of these complex atrial arrhythmias. We\u2019re looking forward to working with this technology and continuing our pursuit of more individualized therapy approaches for our patients.\u201d<\/p>\n

AcQMap 8\u2019s software enhancements also facilitate the seamless integration of Acutus\u2019 AcQBlate FORCE Sensing Ablation Catheter and System* into the AcQMap system, enabling complete visualization and configuration of ablation procedures directly on the AcQMap system\u2019s user interface.<\/p>\n

\u201cOur goal is to give physicians the tools they need to efficiently and effectively treat complex arrhythmias like atrial fibrillation,\u201d said Vince Burgess, President and CEO, Acutus Medical. \u201cWe continue to push the boundaries of what\u2019s possible in the EP lab and take significant technological strides designed to improve patients outcomes. AcQMap 8\u2019s unique automated mapping algorithms and functionalities are a much-needed next step as we continue to drive innovation in the electrophysiology space and help physicians create optimized and personalized treatment strategies for all of their patients.\u201d<\/p>\n

To learn more about Acutus Medical\u2019s complete portfolio of diagnostic, access and therapy products, please visit https:\/\/acutusmedical.com<\/a>.<\/p>\n

*AcQBlate FORCE is currently CE Marked. CAUTION: The AcQBlate FORCE Sensing Catheter and System are investigational devices and are limited by United States law to investigational use.<\/p>\n

\n References<\/strong>
\n
\n 1<\/sup>Willems, et al. \u201cTargeting Nonpulmonary Vein Sources in Persistent Atrial Fibrillation Identified by Noncontact Charge Density Mapping \u2013 UNCOVER AF Trial.\u201d Circulation: Arrhythmia and Electrophysiology<\/em>. Vol. 12, No. 7, 2019.<\/p>\n

\n About Acutus Medical<\/strong>
\n
Acutus Medical is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, Acutus has established a global sales presence delivering a broad portfolio of highly differentiated electrophysiology products that provide its customers with a complete solution for catheter-based treatment of cardiac arrhythmias. Founded in 2011, Acutus<\/a> is based in Carlsbad, California.<\/p>\n

\n Follow Acutus Medical on: <\/strong>
\n Twitter<\/a>, LinkedIn<\/a>, YouTube<\/a> and Facebook<\/a>.<\/p>\n

\n US Media Contacts<\/strong>
\n
Holly Windler
(619) 929-1275
holly.windler@acutus.com<\/a><\/p>\n

Levitate
(260) 408-5383
acutus@levitatenow.com<\/a><\/p>\n

\n Investor Contact<\/strong>
\n
Caroline Corner
(415) 202-5678
caroline.corner@westwicke.com<\/a><\/p>\n

Photos accompanying this announcement are available at <\/p>\n

\n https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/9b6d2593-633e-47c4-a3c0-8d614cd6f70a<\/a>\n <\/p>\n

\n https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/8e471424-2c0f-4593-b105-29f00bca0a44<\/a>\n <\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Enhanced Software Automatically Identifies Regions of Interest During the Treatment of Complex Atrial Arrhythmias CARLSBAD, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (Nasdaq: AFIB) (\u201cAcutus\u201d), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced its innovative suite of software upgrades, known collectively as AcQMap 8, has received FDA clearance and been awarded CE Mark. AcQMap 8 introduces advanced new mapping algorithms into Acutus\u2019 foundational technology, the AcQMap 3D imaging and mapping system. These algorithms \u2013 including AcQTrack\u2122 and the SlowZone\u2122 Locator (Composite Maps) \u2013 are designed to quickly highlight regions of interest during the mapping and ablation of complex atrial arrhythmias, the treatment of which has been shown to … <\/p>\n

Continue reading “AcQMap 8, Acutus Medical\u2019s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-526542","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAcQMap 8, Acutus Medical\u2019s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AcQMap 8, Acutus Medical\u2019s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Enhanced Software Automatically Identifies Regions of Interest During the Treatment of Complex Atrial Arrhythmias CARLSBAD, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (Nasdaq: AFIB) (\u201cAcutus\u201d), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced its innovative suite of software upgrades, known collectively as AcQMap 8, has received FDA clearance and been awarded CE Mark. AcQMap 8 introduces advanced new mapping algorithms into Acutus\u2019 foundational technology, the AcQMap 3D imaging and mapping system. These algorithms \u2013 including AcQTrack\u2122 and the SlowZone\u2122 Locator (Composite Maps) \u2013 are designed to quickly highlight regions of interest during the mapping and ablation of complex atrial arrhythmias, the treatment of which has been shown to … Continue reading "AcQMap 8, Acutus Medical\u2019s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-11T12:03:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwNjg3NSM0MzUyMzQ3IzIyMDAwNjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AcQMap 8, Acutus Medical\u2019s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark\",\"datePublished\":\"2021-08-11T12:03:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\\\/\"},\"wordCount\":920,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwNjg3NSM0MzUyMzQ3IzIyMDAwNjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\\\/\",\"name\":\"AcQMap 8, Acutus Medical\u2019s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwNjg3NSM0MzUyMzQ3IzIyMDAwNjY=\",\"datePublished\":\"2021-08-11T12:03:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwNjg3NSM0MzUyMzQ3IzIyMDAwNjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwNjg3NSM0MzUyMzQ3IzIyMDAwNjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AcQMap 8, Acutus Medical\u2019s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AcQMap 8, Acutus Medical\u2019s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/","og_locale":"en_US","og_type":"article","og_title":"AcQMap 8, Acutus Medical\u2019s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark - Market Newsdesk","og_description":"Enhanced Software Automatically Identifies Regions of Interest During the Treatment of Complex Atrial Arrhythmias CARLSBAD, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (Nasdaq: AFIB) (\u201cAcutus\u201d), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced its innovative suite of software upgrades, known collectively as AcQMap 8, has received FDA clearance and been awarded CE Mark. AcQMap 8 introduces advanced new mapping algorithms into Acutus\u2019 foundational technology, the AcQMap 3D imaging and mapping system. These algorithms \u2013 including AcQTrack\u2122 and the SlowZone\u2122 Locator (Composite Maps) \u2013 are designed to quickly highlight regions of interest during the mapping and ablation of complex atrial arrhythmias, the treatment of which has been shown to … Continue reading \"AcQMap 8, Acutus Medical\u2019s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-11T12:03:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwNjg3NSM0MzUyMzQ3IzIyMDAwNjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AcQMap 8, Acutus Medical\u2019s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark","datePublished":"2021-08-11T12:03:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/"},"wordCount":920,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwNjg3NSM0MzUyMzQ3IzIyMDAwNjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/","name":"AcQMap 8, Acutus Medical\u2019s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwNjg3NSM0MzUyMzQ3IzIyMDAwNjY=","datePublished":"2021-08-11T12:03:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwNjg3NSM0MzUyMzQ3IzIyMDAwNjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwNjg3NSM0MzUyMzQ3IzIyMDAwNjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance-and-ce-mark\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AcQMap 8, Acutus Medical\u2019s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/526542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=526542"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/526542\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=526542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=526542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=526542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}